- Home
- PSTL vs PRQR Comparison
PSTL vs PRQR Comparison
Compare PSTL & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTL
- PRQR
- Stock Information
- Founded
- PSTL 2018
- PRQR 2012
- Country
- PSTL United States
- PRQR Netherlands
- Employees
- PSTL N/A
- PRQR N/A
- Industry
- PSTL Real Estate Investment Trusts
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- PSTL Real Estate
- PRQR Health Care
- Exchange
- PSTL Nasdaq
- PRQR Nasdaq
- Market Cap
- PSTL 335.6M
- PRQR 309.5M
- IPO Year
- PSTL 2019
- PRQR 2014
- Fundamental
- Price
- PSTL $13.43
- PRQR $1.14
- Analyst Decision
- PSTL Strong Buy
- PRQR Strong Buy
- Analyst Count
- PSTL 1
- PRQR 6
- Target Price
- PSTL $15.50
- PRQR $8.50
- AVG Volume (30 Days)
- PSTL 165.9K
- PRQR 628.0K
- Earning Date
- PSTL 05-06-2025
- PRQR 05-08-2025
- Dividend Yield
- PSTL 7.23%
- PRQR N/A
- EPS Growth
- PSTL 83.16
- PRQR N/A
- EPS
- PSTL 0.21
- PRQR N/A
- Revenue
- PSTL $76,372,000.00
- PRQR $20,235,014.00
- Revenue This Year
- PSTL $13.87
- PRQR $6.44
- Revenue Next Year
- PSTL $10.76
- PRQR N/A
- P/E Ratio
- PSTL $63.07
- PRQR N/A
- Revenue Growth
- PSTL 19.87
- PRQR 196.41
- 52 Week Low
- PSTL $12.26
- PRQR $1.07
- 52 Week High
- PSTL $15.15
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- PSTL 47.66
- PRQR 28.23
- Support Level
- PSTL $12.52
- PRQR $1.08
- Resistance Level
- PSTL $14.35
- PRQR $1.26
- Average True Range (ATR)
- PSTL 0.41
- PRQR 0.13
- MACD
- PSTL -0.05
- PRQR 0.02
- Stochastic Oscillator
- PSTL 53.30
- PRQR 21.87
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.